agilon health, inc.
AGL- Exchange
- NYSE
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001831097
No open-market purchases or sales by agilon health, inc. insiders were filed in the last 90 days; 179 institutions reported holding it in 13F filings for Q2 2026, worth $1.73B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +83 vs. previous quarter
- 179
- 13F valueReported value at the end of Q2 2026
- $1.73B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding AGL, Q2 2026
No superinvestor reported holding AGL at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by agilon health, inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 (view filing) | Mar 9 | 2 days | Zamore DeniseChief Legal Officer | PPurchase | +5.54K | – | – | +1.2%448.7K after | |
| Mar 11, 2026 (view filing) | Mar 9 | 2 days | Venkatachaliah GirishChief Technology Officer | PPurchase | +18.4K | – | – | +6.9%285.1K after | |
| Mar 11, 2026 (view filing) | Mar 9 | 2 days | Shaker BenjaminChief Markets Officer | PPurchase | +18.4K | – | – | +1.3%1.39M after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Shaker BenjaminChief Markets Officer | PPurchase | +500.0K | $0.60 | +$300.0K | +57.6%1.37M after | |
| Jan 30, 2026 (view filing) | Nov 12, 2025 | 79 daysLate | Wulf John WilliamDirector | PPurchase | +81.0K | $0.63 | +$51.0K | +28.4%365.9K after | |
| Apr 3, 2025 (view filing) | Nov 29, 2023 | 491 days | Schwaneke Jeffrey A.Chief Financial Officer | PPurchase | +22.3K | $11.22 | +$250.2K | New position22.3K after | Amended |
| Mar 18, 2025 (view filing) | Mar 14 | 4 days | Sell StevenCEO & President | PPurchase | +42.4K | – | – | +12.9%370.9K after | |
| Mar 18, 2025 (view filing) | Mar 14 | 4 days | Shaker BenjaminChief Markets Officer | PPurchase | +11.8K | – | – | +2.6%461.2K after | |
| Mar 18, 2025 (view filing) | Mar 14 | 4 days | Venkatachaliah GirishChief Technology Officer | PPurchase | +9.43K | – | – | +6.3%158.4K after | |
| Dec 13, 2024 (view filing) | Dec 13 | Same day | McLoughlin KarenDirector | PPurchase | +25.0K | $2.20 | +$55.0K | +51.9%73.2K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in agilon health, inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Clayton, Dubilier & Rice, LLC | 4,000,000 | $428.7M | 47.90% | 00.0% | Unchanged |
| Morgan Stanley | 2,011,196 | $215.6M | 0.01% | −88,255−4.2% | Reduced |
| North Peak Capital Management, LLC | 1,485,066 | $159.2M | 17.69% | −60,471−3.9% | Reduced |
| BlackRock, Inc. | 1,146,520 | $122.9M | 0.00% | +273,356+31.3% | Added |
| AQR Capital Management LLC | 692,541 | $74.2M | 0.03% | −282,356−29.0% | Reduced |
| Goldman Sachs Group Inc | 686,792 | $73.6M | 0.01% | −375,444−35.3% | Reduced |
| Vanguard Capital Management LLC | 525,328 | $56.3M | 0.00% | −13,208−2.5% | Reduced |
| Marshall Wace, LLP | 468,293 | $50.2M | 0.04% | +468,293 | New |
| Durable Capital Partners LP | 440,642 | $47.2M | 0.46% | +440,642 | New |
| D. E. Shaw & Co., Inc. | 390,149 | $41.8M | 0.03% | −352,069−47.4% | Reduced |